Earnings Releases·Nov 3, 2026, 8:12 AM ET

IPG Photonics — Third Quarter 2026 Earnings Summary

Revenue grew 15% year-over-year to $287.5 million for the quarter and 14% to $831.6 million for the nine months, driven by 12% and 16% growth in the Industrial Solutions segment and 33% and 5% growth in Advanced Solutions, respectively.
Profitability metrics expanded significantly, with GAAP gross margin rising to 40.7% (from 39.5%) and net income surging 171% to $20.3 million for the quarter, supported by a 1% revenue boost from foreign exchange and $5.0 million in net tariff refunds.
The company provided Q4 2026 guidance anticipating revenue between $265 million and $295 million and adjusted EPS between $0.30 and $0.60, explicitly excluding contributions from the anticipated acquisition of Lumibird Medical.
Strategic progress includes a book-to-bill ratio of approximately one, a 33% sales increase in North America, and the expectation that the Lumibird Medical acquisition will close in Q4 to accelerate growth in medical markets.
Capital allocation saw $2.6 million spent on treasury stock purchases over the nine months, while cash and cash equivalents increased to $710.7 million as of September 30, 2026.